Debio1347, an oral FGFR inhibitor: Results from a single-center study in pediatric patients with recurrent or refractory FGFR-altered gliomas Journal Article

   

Authors:	Sait, S. F.; Gilheeney, S. W.; Bale, T. A.; Haque, S.; Dinkin, M. J.; Vitolano, S.; Rosenblum, M. K.; Ibanez, K.; Prince, D. E.; Spatz, K. H.; Dunkel, I. J.; Karajannis, M. A.
Article Title:	Debio1347, an oral FGFR inhibitor: Results from a single-center study in pediatric patients with recurrent or refractory FGFR-altered gliomas
Journal Title:	JCO Precision Oncology
Volume:	5
ISSN:	2473-4284
Publisher:	American Society of Clinical Oncology
Date Published:	2021-01-01
Start Page:	876
End Page:	883
Language:	English
DOI:	10.1200/po.20.00444
PROVIDER:	scopus
PMCID:	PMC8232545
PUBMED:	34250399
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117694897&doi=10.1200%2fPO.20.00444&partnerID=40&md5=2ff00eb5360bdb0e0a9adec6830d1144
Notes:	Article -- Export Date: 2 November 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/188787